Artificial Intelligence-Based Automatic Recognition and Localization of Anatomical Sites in Colonoscopy

September 24, 2026 updated by: Xiuli Zuo

This study aims to develop, validate and evaluate an artificial intelligence-based system for real-time automatic localization of colorectal anatomical sites during colonoscopy and detection of colonoscopic inspection extent, so as to improve examination quality and the precision of lesion management. The hypothesis of this study is that a colonoscopic image recognition model built on deep convolutional neural networks can accurately extract intestinal anatomical features from endoscopic video frames. In prospective and retrospective independent validation cohorts, the artificial intelligence model is hypothesized to achieve an overall accuracy of no less than 85% for the multi-class anatomical site localization task across colonic segments, with an expected sensitivity of 90% and specificity of 85%. The model predictions are expected to be in high agreement with assessments by senior endoscopists, with an anticipated Kappa coefficient of 0.80. This will verify the technical feasibility and accuracy of deep learning-driven real-time anatomical localization during colonoscopy.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Not yet recruiting

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Observational

Enrollment (Estimated)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
8000

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

18 years to 75 years (Adult, Older Adult)

Accepts Healthy Volunteers

N/A

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Participants aged 18-75 years scheduled for colonoscopy, with successful cecal intubation and adequate bowel preparation. Colonoscopic videos are collected to validate an AI system for real-time anatomical site recognition and localization.

Description

Inclusion Criteria:

  1. Aged 18-75 years, male or female;
  2. Undergoing colonoscopy;
  3. Successful cecal intubation with the endoscope reaching the ileocecal valve;
  4. Adequate colonic cleansing, with a Boston Bowel Preparation Scale (BBPS) score ≥2 points in each of the three colonic segments.

Exclusion Criteria:

  1. Reduced life expectancy;
  2. Active gastrointestinal bleeding;
  3. History of lower gastrointestinal tract surgery;
  4. Previous history of colorectal cancer or adenomas;
  5. Prior history of sessile serrated polyps greater than 10 mm in diameter;
  6. Ongoing chemotherapy or radiotherapy;
  7. Diagnosis of inflammatory bowel disease;
  8. Intestinal diseases identified during the current examination, including colorectal cancer, colorectal polyps and inflammatory bowel disease;
  9. Pregnant or lactating women, and participants unwilling to use contraception during the study;
  10. Other behaviours that may increase disease risk, such as heavy alcohol consumption and drug abuse;
  11. Participants unable or unwilling to provide written informed consent;
  12. Unclear colonoscopy videos;
  13. Incomplete colonoscopy videos.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: OTHER
  • Time Perspectives: OTHER

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
Accuracy
Time Frame: through study completion, an average of 1 year

The percentage of samples in which the artificial intelligence model correctly identifies the corresponding intestinal anatomical sites across all endoscopic video frames, relative to the total sample size enrolled in the study. This metric reflects the overall classification accuracy of the model.
through study completion, an average of 1 year
Sensitivity
Time Frame: through study completion, an average of 1 year

The proportion of all true positive samples annotated as a specific intestinal segment by endoscopy experts that are correctly identified as this segment by the artificial intelligence model. This metric primarily evaluates the model's ability to avoid missed detection of the target anatomical site.
through study completion, an average of 1 year
F1-score
Time Frame: through study completion, an average of 1 year

To address the problem of "class imbalance" caused by variable colonoscopy examination time across different intestinal segments, this study adopts the F1-score for comprehensive evaluation. The calculation is performed as follows: first, the precision for a specific intestinal segment is obtained; then the harmonic mean of this precision and sensitivity is calculated. To assess overall performance, the arithmetic mean of the F1-scores for all intestinal segment classifications is finally computed (i.e., macro-averaged F1-score).
through study completion, an average of 1 year
Macro-AUC
Time Frame: through study completion, an average of 1 year

The receiver operating characteristic (ROC) curve reflects the model's overall discriminative performance under different decision thresholds. For this multi-class classification task, the calculation proceeds as follows: each specific intestinal segment is treated as the positive class one by one; the corresponding ROC curve is plotted and the area under the curve (AUC) is calculated for each segment. Thereafter, the arithmetic mean of AUC values across all anatomical categories is computed to obtain the macro-averaged AUC, which serves as the composite metric for evaluating the overall multi-class discriminative ability of the model.
through study completion, an average of 1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
Xiuli Zuo

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
October 1, 2026

Primary Completion (Estimated)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
January 1, 2028

Study Completion (Estimated)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
March 1, 2028

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
September 6, 2026

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
September 24, 2026

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
September 30, 2026

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
September 30, 2026

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
September 24, 2026

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
September 1, 2026

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • KYLL-2026-03-062-1

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings